{{Infobox drug
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 464386379
| drug_name =
| INN =
| type =
| image = Salmeterol.svg
| width = 220
| alt =
| caption =
| chirality = Racemic mixture
| pronounce =
| tradename = Serevent, Aeromax, others
| Drugs.com =
| MedlinePlus =
| licence_CA =
| licence_EU = yes
| DailyMedID = Salmeterol
| licence_US =
| pregnancy_AU = B3
| pregnancy_AU_comment =
| pregnancy_category=
| dependency_liability =
| addiction_liability =
| routes_of_administration = Respiratory inhalation (Metered-dose inhaler (MDI), Dry-powder inhaler (DPI))
| class =
| ATCvet =
| ATC_prefix = R03
| ATC_suffix = AC12
| ATC_supplemental =
| legal_AU = S4
| legal_AU_comment =
| legal_BR =
| legal_BR_comment =
| legal_CA = Rx-only
| legal_CA_comment =
| legal_DE =
| legal_DE_comment =
| legal_NZ =
| legal_NZ_comment =
| legal_UK = POM
| legal_UK_comment =
| legal_US = Rx-only
| legal_US_comment =
| legal_EU =
| legal_EU_comment =
| legal_UN =
| legal_UN_comment =
| legal_status = Rx-only
| bioavailability =
| protein_bound = 96%
| metabolism = Liver (CYP3A4)
| metabolites =
| onset =
| elimination_half-life = 5.5 hours
| duration_of_action =
| excretion =
| CAS_number_Ref =
| CAS_number = 89365-50-4
| CAS_supplemental =
| PubChem = 5152
| IUPHAR_ligand = 559
| DrugBank_Ref =
| DrugBank = DB00938
| ChemSpiderID_Ref =
| ChemSpiderID = 7987886
| UNII_Ref =
| UNII = 2I4BC502BT
| KEGG_Ref =
| KEGG = D05792
| ChEBI_Ref =
| ChEBI = 9011
| ChEMBL_Ref =
| ChEMBL = 1263
| NIAID_ChemDB =
| PDB_ligand = K5Y
| synonyms =
| IUPAC_name = (RS)-2-(hydroxymethyl)-4-{1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl}phenol
| C=25 | H=37 | N=1 | O=4
| SMILES = OCc1cc(ccc1O)C@HCNCCCCCCOCCCCc2ccccc2
| StdInChI_Ref =
| StdInChI = 1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2/t25-/m1/s1
| StdInChI_comment =
| StdInChIKey_Ref =
| StdInChIKey = GIIZNNXWQWCKIB-RUZDIDTESA-N
| density =
| density_notes =
| melting_point =
| melting_high =
| melting_notes =
| boiling_point =
| boiling_notes =
| solubility =
| sol_units =
| specific_rotation =
}}
沙美特罗 是一种用于预防哮喘以及慢性阻塞性肺病突然發作的藥物。 這些疾病發作時的症状有呼吸困难、喘鳴、咳嗽和胸闷。它可以用于预防运动期间出現的呼吸困难。
研發沙美特羅的製藥廠於1983年获得沙美特羅的专利。1990年,沙美特羅投入臨床使用。
参考文献
外部链接
*
评论 (0)